PANCAD.AI CO., LTD.
Area: MOST Inno Zone
Booth No: N915
Website: https://www.pancad.ai
Exhibitor Profile
Approximately detecting pancreatic cancer while the tumor is smaller than 2 cm represents the only chance of cure, but approximately 40% of PCs smaller than 2 cm are missed on the major detection modality of CT. PanCAD.ai, a spinoff of National Taiwan University supported by Germination Program of National Science and Technology Council, has developed a novel AI CADe/x tool (PANCREASaver) that can improve the detection of PC on contrast-enhanced CT to address the pressing unmet need. PANCREASaver has been approved by TFDA and designated as Breakthrough Device by US FDA.
Brands
PANCREASaver
Exhibitors you may be interested in
Highest Rated